InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories

IDXX Clue Score66
United States Fiscal year ends December CIK 0000874716 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Andrew Emerson
20 Aug 2026
EVP, CFO and Treasurer
Exercised, kept
265
$178.26
$47.24K
Sharon E. Underberg
3 Mar 2026
EVP, GC & Corporate Secretary
Exercised, kept
197
$505.53
$99.59K
Jonathan Jay Mazelsky
27 Feb 2026
President and CEO
Exercised, kept
197
$505.53
$99.59K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
197
$505.53
$99.59K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
183
$544.08
$99.57K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
483
$206.94
$99.95K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
817
$178.26
$145.64K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
719
$141.60
$101.81K
George Fennell
9 Feb 2026
Executive Vice President
Exercised, kept
1,476
$67.85
$100.15K
Show all 66 transactions →

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 50
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 115,424
History held since 1 Nov 2006